U.S. FDA Grants Traditional Approval to Leqembi (Lecanemab-Irmb) for Alzheimer’s Disease Treatment. BONITA SPRINGS, FL July 6, 2023 – FDA Grants Traditional Approval to Leqembi (Lecanemab-Irmb) for Alzheimer’s Disease Treatment. In a groundbreaking move, Leqembi has received traditional approval from the FDA for the treatment
Memory Treatment Centers at the forefront of Alzheimer’s treatment innovation, as featured in the Wall Street Journal Memory Treatment Centers neurologist, Jamie Plante and current Leqembi patient were interviewed by the Wall Street Journal to investigate availability of new Alzheimers treatments. With the recent FDA
Memory Treatment Centers, a leading neurocognitive disease clinic, is proud to be one of the first medical organizations in the United States to offer the innovative Alzheimer’s drug Leqembi (lecanemab-irmb). Bonita Springs, FL February 6, 2023 – Last week, Memory Treatment Centers (MTC) became amongst
Memory Treatment Centers Applauds U.S. FDA Approval of Leqembi (Lecanemab) BONITA SPRING, FL, January 10, 2023 — Memory Treatment Centers are pleased to announce that the Food and Drug Administration (FDA) has approved Lecanemab, a new drug for the treatment of Alzheimer’s disease. This is an